Nexium capsules Clinical Experience Investigation
Study identifier:D961HC00010
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Nexium capsules Clinical Experience Investigation
Medical condition
gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis,"non-erosive reflux disease, Zollinger-Ellison syndrome
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
3691
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Sept 2011
Primary Completion Date: 01 Mar 2014
Study Completion Date: 01 Mar 2014
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Aug 2014 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Nexium | - |
Contacts
Investigators
Principal Investigator
Shigeru Yoshida
Astrazeneca K.K.
